StockMarketWire.com - Mediclinic International posted a 4% fall in its full-year adjusted earnings, in line with expectations, due to a changing regulatory environment in Switzerland, the location of its Hirslanden hospital group. However, the company left its guidance unchanged.

Adjusted Ebitda fell 4% to £493m for the year to 31 March 2019, while revenue grew 2% to £2.932bn.

"Over the course of the last 18 months, all Swiss hospital operators have been affected by rapidly implemented regulatory changes related to outpatient tariff reductions and outmigration of care. We took actions to improve Hirslanden's performance, including accelerated cost-saving initiatives and the introduction of operational efficiencies.

"As these plans started to take effect, they moderated the financial impact of the regulatory changes in the second half of the year, with Hirslanden delivering a 16% EBITDA margin for the full year, in line with guidance," said CEO Ronnie van der Merwe.

The company maintained its proposed final dividend at 4.7p/share with the total dividend for the year at 7.9p/share.








Story provided by StockMarketWire.com